OxRML/AgentSLR huggingface dataset:
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value:  No units ()
Exponent (base 10): 0
Bounds: 0.7 - 2.2
Statistical approach: Estimated model parameter
Disaggregated by: Time
Reproduction number method: Branching process Human-human
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Study period: 2015
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 7 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 4 - 10 (95% CI)
Numerator/denominator:  / 249 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 249
Study period: Oct 2014
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 8 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 6 - 10 (95% CI)
Numerator/denominator:  / 675 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 675
Study period: Mar 2015
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 63 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 60 - 65 (95% CI)
Numerator/denominator:  / 1453 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Region
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 1453
Study period: Oct 2015
Parameter: Seroprevalence - IgG (Seroprevalence)
Exponent (base 10): 0
Numerator/denominator: 393 / 642 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 642
Study period: Oct 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 1 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 0 - 4 (95% CI)
Numerator/denominator:  / 101 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 101
Study period: Mar 2015
Parameter: Seroprevalence - HAI/HI (Seroprevalence)
Value: 6 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 8 / 132 (method: Naive)
Seroprevalence adjustment: Naive
Disaggregated by: Region
Trimester exposed: Unspecified
Population: General population, sex: Both, ages 20 to 40
Country: Uganda
Location: Karamoja District
Setting: Community based, Unspecified
Sample size: 132
Study period: May 1984
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.1 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Guadeloupe
Setting: Population based, 
Sample size: 717
Study period: 29 Jan 2016 - 10 Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 7.2 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Martinique
Setting: Population based, 
Sample size: 102
Study period: 21 Dec 2015 - 21 Jan 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.8 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Dominican Republic
Setting: Population based, 
Sample size: 573
Study period: 30 Jan 2016 - 27 Feb 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.1 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Mexico
Setting: Population based, 
Sample size: 129
Study period: 1 Jan 2016 - 13 Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 5 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Guatemala
Setting: Population based, 
Sample size: 386
Study period: 16 Nov 2015 - 15 Feb 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.9 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Panama
Setting: Population based, 
Sample size: 49
Study period: 1 Jan 2016 - 13 Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3.7 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: United States
Location: Puerto Rico
Setting: Population based, 
Sample size: 198
Study period: 26 Nov 2015 - 24 Feb 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 4.8 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: El Salvador
Setting: Population based, 
Sample size: 5618
Study period: 1 Jan 2016 - 13 Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3.2 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Colombia
Setting: Population based, 
Sample size: 1593
Study period: 1 Jan 2016 - 13 Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 7 No units (Mean)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Ecuador
Setting: Population based, 
Sample size: 96
Study period: 1 Jan 2016 - 13 Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.54 - 1.9
Statistical approach: Estimated model parameter
Disaggregated by: Method, Time
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Guadeloupe
Setting: Community based, 
Study period: 24 Jan 2015 - 29 Jan 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.3 - 1.62
Statistical approach: Estimated model parameter
Disaggregated by: Method, Time
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Martinique
Setting: Community based, 
Study period: 20 Dec 2015 - 5 Feb 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.34 - 1.57
Statistical approach: Estimated model parameter
Disaggregated by: Method, Time
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Saint Martin
Setting: Community based, 
Study period: 24 Jan 2015 - 19 Feb 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.03 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.63 - 2.36 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Australes, French Polynesia
Setting: Community based, 
Study period: 1 Dec 2015 - 30 Mar 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.12 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.82 - 2.47 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Marquesas Islands, French Polynesia
Setting: Community based, 
Study period: 27 Oct 2015 - 23 Mar 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.1 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.78 - 2.47 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Community based, 
Study period: 27 Oct 2015 - 9 Mar 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.1 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.8 - 2.43 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Sous-le-vent Islands, French Polynesia
Setting: Community based, 
Study period: 27 Oct 2015 - 23 Mar 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.1 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.86 - 2.35 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Community based, 
Study period: 13 Oct 2015 - 16 Mar 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.05 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.71 - 2.37 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tuamotu, French Polynesia
Setting: Community based, 
Study period: 20 Oct 2015 - 2 Mar 2017
Parameter: Human delay - generation time (Human delay)
Value: 2.5 Weeks (Mean)
Exponent (base 10): 0
Uncertainty: 0.7 (Standard Deviation)
Uncertainty (single): 0.7 (Standard Deviation)
Distribution: Gamma
Statistical approach: Estimated model parameter
Country: France
Location: Guadeloupe, Martinique, Saint-Martin
Study period: 2015 - 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.88 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.59 - 2.22 (95% CrI)
Statistical approach: Estimated model parameter
Disaggregated by: Region
Reproduction number method: Branching process Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: French Polynesia and French West Indies
Setting: Population based, 
Sample size: 100000
Study period: Oct 2013 - Oct 2016
Parameter: Human delay - serial interval (Human delay)
Value:  Weeks (Mean)
Exponent (base 10): 0
Bounds: 2.2 - 4.7
Statistical approach: Estimated model parameter
Disaggregated by: Region
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Oct 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.75 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 2.53 - 2.98 (95% CI)
Statistical approach: Estimated model parameter
Population: Unspecified, sex: Unspecified, ages  to 
Country: France
Location: French Polynesia
Setting: Unspecified, Unspecified
Study period: 2013 - Unspecified
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 95 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 20 / 21 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: France
Location: Tahiti, Mo'orea, French Polynesia
Setting: Hospital based, Unspecified
Sample size: 21
Study period: 1 Jun 2013 - 31 Aug 2014
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 76 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 78 / 102 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: France
Location: Tahiti, Mo'orea, French Polynesia
Setting: Hospital based, Unspecified
Sample size: 102
Study period: 1 Jun 2013 - 31 Aug 2014
Parameter: Human delay - Onset of previous illness to Onset of neurologic symptoms (Human delay)
Value: 8 Days (Median)
Exponent (base 10): 0
Uncertainty: 5 - 15 (IQR)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 50
Study period: 1 Jan 2015 - 31 Aug 2015
Parameter: Human delay - Onset of neurologic symptoms to Nadir of neurologic symptoms (Human delay)
Value: 6 Days (Median)
Exponent (base 10): 0
Uncertainty: 4 - 9 (IQR)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 50
Study period: 1 Jan 2015 - 31 Aug 2015
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 41 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 17 / 41 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 41
Study period: 1 Jan 2015 - 31 Aug 2015
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 36 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 30 / 84 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 84
Study period: 1 Jan 2015 - 31 Aug 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 88 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 36 / 41 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 41
Study period: 1 Jan 2015 - 31 Aug 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 76 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 64 / 84 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 84
Study period: 1 Jan 2015 - 31 Aug 2015
Parameter: Seroprevalence - IgM (Seroprevalence)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 9 / 13845 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Population: Persons under investigation, sex: Both, ages 1 to 90
Country: Senegal
Location: Kedougou
Setting: Hospital based, Rural area
Sample size: 13845
Study period: Jul 2009 - Mar 2013
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 62.7 Percentage (%) (Other)
Exponent (base 10): 0
Uncertainty: 59.4 - 66.1 (95% CI)
Bounds: 6 - 83
Numerator/denominator: 530 / 845 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Region, Sex
Population: Other, sex: Both, ages  to 
Country: Sudan
Setting: Community based, Both urban and rural areas
Sample size: 845
Study period: 2012
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Exponent (base 10): 0
Numerator/denominator: 1 / 530 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Sudan
Setting: Community based, Both urban and rural areas
Sample size: 530
Study period: 2012
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 17.3 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Unspecified
Numerator/denominator: 62 / 359 (method: Unspecified)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Blood donors, sex: Both, ages 16 to 63
Country: Laos
Location: Vientiane capital
Setting: Population based, Unspecified
Sample size: 359
Study period: 2003 - 2004
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 27.9 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Unspecified
Numerator/denominator: 192 / 687 (method: Unspecified)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Blood donors, sex: Both, ages 17 to 79
Country: Laos
Location: Vientiane capital
Setting: Population based, Unspecified
Sample size: 687
Study period: 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value:  Percentage (%) (Unspecified)
Exponent (base 10): 0
Bounds: 3.9 - 10.1
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex, Time
Trimester exposed: Unspecified
Population: Blood donors, sex: Both, ages 15 to 
Country: Laos
Location: Vientiane capital
Setting: Population based, Unspecified
Study period: 2003 - 2015
Parameter: Seroprevalence - IgM (Seroprevalence)
Exponent (base 10): 0
Case definition: Unspecified
Numerator/denominator: 5 / 73 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages 0 to 0
Country: Argentina
Setting: Other, Unspecified
Sample size: 104
Study period: Apr 2016 - Mar 2017
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 61.9 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed;Other
Numerator/denominator: 65 / 105 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Beni
Setting: Population based, 
Sample size: 105
Study period: Dec 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 61 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed;Other
Numerator/denominator: 122 / 200 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Santa Cruz
Setting: Population based, 
Sample size: 200
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 9.7 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed;Other
Numerator/denominator: 19 / 196 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Tarija
Setting: Population based, 
Sample size: 196
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 1.9 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed;Other
Numerator/denominator: 3 / 162 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: La Paz
Setting: Population based, 
Sample size: 162
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 2.6 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed;Other
Numerator/denominator: 4 / 152 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Cochabamba
Setting: Population based, 
Sample size: 152
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 39 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 30 - 48 (95% CI)
Case definition: Lab confirmed;Other
Numerator/denominator: 41 / 70 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Beni
Setting: Population based, 
Sample size: 70
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 21.5 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 16 - 27 (95% CI)
Case definition: Lab confirmed;Other
Numerator/denominator: 43 / 134 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Santa Cruz
Setting: Population based, 
Sample size: 134
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 0.5 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 0 - 1.5 (95% CI)
Case definition: Lab confirmed;Other
Numerator/denominator: 1 / 22 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Tarija
Setting: Population based, 
Sample size: 22
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 0 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 0 - 0 (95% CI)
Case definition: Lab confirmed;Other
Numerator/denominator: 0 / 4 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: La Paz
Setting: Population based, 
Sample size: 4
Study period: Mar 2017 - Apr 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 0 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 0 - 0 (95% CI)
Case definition: Lab confirmed;Other
Numerator/denominator: 0 / 7 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages  to 
Country: Bolivia
Location: Cochabamba
Setting: Population based, 
Sample size: 7
Study period: Mar 2017 - Apr 2017
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.12 No units (Median)
Exponent (base 10): 0
Bounds: 0.98 - 56.38
Statistical approach: Estimated model parameter
Disaggregated by: Region
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: Both, ages  to 
Country: Colombia
Location: Antioquia
Setting: Population based, Both urban and rural areas
Sample size: 1841
Study period: 1 Jan 2016 - 11 Apr 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 56.38 No units (Median)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: Both, ages  to 
Country: Colombia
Location: Cáceres
Setting: Population based, Both urban and rural areas
Sample size: 1841
Study period: 1 Jan 2016 - 11 Apr 2016